These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 15485693

  • 1. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells.
    Narumiya H, Sasaki S, Kuwahara N, Irie H, Kusaba T, Kameyama H, Tamagaki K, Hatta T, Takeda K, Matsubara H.
    Cardiovasc Res; 2004 Nov 01; 64(2):331-6. PubMed ID: 15485693
    [Abstract] [Full Text] [Related]

  • 2. HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis.
    Kuwahara N, Sasaki S, Kobara M, Nakata T, Tatsumi T, Irie H, Narumiya H, Hatta T, Takeda K, Matsubara H, Hushiki S.
    Int J Cardiol; 2008 Jan 11; 123(2):84-90. PubMed ID: 17434618
    [Abstract] [Full Text] [Related]

  • 3. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
    Rodríguez C, Alcudia JF, Martínez-González J, Guadall A, Raposo B, Sánchez-Gómez S, Badimon L.
    Cardiovasc Res; 2009 Aug 01; 83(3):595-603. PubMed ID: 19406911
    [Abstract] [Full Text] [Related]

  • 4. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway.
    Hiraoka M, Nitta N, Nagai M, Shimokado K, Yoshida M.
    Life Sci; 2004 Jul 30; 75(11):1333-41. PubMed ID: 15234191
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y, Kimoto K, Imaizumi M, Nakatsuka K.
    Exp Eye Res; 2007 Mar 30; 84(3):464-72. PubMed ID: 17217948
    [Abstract] [Full Text] [Related]

  • 6. Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation.
    Dechend R, Gieffers J, Dietz R, Joerres A, Rupp J, Luft FC, Maass M.
    Circulation; 2003 Jul 22; 108(3):261-5. PubMed ID: 12860900
    [Abstract] [Full Text] [Related]

  • 7. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K, Adachi S, Maejima Y, Tamamori-Adachi M, Suzuki J, Kitajima S, Ito H, Isobe M.
    Life Sci; 2006 Aug 29; 79(14):1380-90. PubMed ID: 16712874
    [Abstract] [Full Text] [Related]

  • 8. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes.
    Blanco-Colio LM, Muñoz-García B, Martín-Ventura JL, Lorz C, Díaz C, Hernández G, Egido J.
    Circulation; 2003 Sep 23; 108(12):1506-13. PubMed ID: 12952848
    [Abstract] [Full Text] [Related]

  • 9. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.
    Massaro M, Zampolli A, Scoditti E, Carluccio MA, Storelli C, Distante A, De Caterina R.
    Cardiovasc Res; 2010 May 01; 86(2):311-20. PubMed ID: 19946014
    [Abstract] [Full Text] [Related]

  • 10. Impact of HMG CoA reductase inhibition on small GTPases in the heart.
    Laufs U, Kilter H, Konkol C, Wassmann S, Böhm M, Nickenig G.
    Cardiovasc Res; 2002 Mar 01; 53(4):911-20. PubMed ID: 11922901
    [Abstract] [Full Text] [Related]

  • 11. RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation.
    Fromigué O, Haÿ E, Modrowski D, Bouvet S, Jacquel A, Auberger P, Marie PJ.
    Cell Death Differ; 2006 Nov 01; 13(11):1845-56. PubMed ID: 16470222
    [Abstract] [Full Text] [Related]

  • 12. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux.
    Argmann CA, Edwards JY, Sawyez CG, O'Neil CH, Hegele RA, Pickering JG, Huff MW.
    J Biol Chem; 2005 Jun 10; 280(23):22212-21. PubMed ID: 15817453
    [Abstract] [Full Text] [Related]

  • 13. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells.
    Li M, Li Z, Sun X.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):219-23. PubMed ID: 18619957
    [Abstract] [Full Text] [Related]

  • 14. Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell.
    Maejima T, Yamazaki H, Aoki T, Tamaki T, Sato F, Kitahara M, Saito Y.
    Biochem Biophys Res Commun; 2004 Nov 12; 324(2):835-9. PubMed ID: 15474503
    [Abstract] [Full Text] [Related]

  • 15. Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104).
    Han J, Parsons M, Zhou X, Nicholson AC, Gotto AM, Hajjar DP.
    Circulation; 2004 Nov 30; 110(22):3472-9. PubMed ID: 15557368
    [Abstract] [Full Text] [Related]

  • 16. Atorvastatin inhibits myocardin expression in vascular smooth muscle cells.
    Li J, Jiang J, Yin H, Wang L, Tian R, Li H, Wang Z, Li D, Wang Y, Gui Y, Walsh MP, Zheng XL.
    Hypertension; 2012 Jul 30; 60(1):145-53. PubMed ID: 22615115
    [Abstract] [Full Text] [Related]

  • 17. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
    Wei CY, Huang KC, Chou YH, Hsieh PF, Lin KH, Lin WW.
    Mol Pharmacol; 2006 Mar 30; 69(3):960-7. PubMed ID: 16317111
    [Abstract] [Full Text] [Related]

  • 18. Expression of RhoA mRNA and activated RhoA in urothelium and smooth muscle, and effects of a Rho-kinase inhibitor on contraction of the porcine urinary bladder.
    Nakanishi K, Kamai T, Mizuno T, Arai K, Yamanishi T.
    Neurourol Urodyn; 2009 Mar 30; 28(6):521-8. PubMed ID: 19214992
    [Abstract] [Full Text] [Related]

  • 19. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells.
    Rodrigues AC, Curi R, Hirata MH, Hirata RD.
    Eur J Pharm Sci; 2009 Jun 28; 37(3-4):486-91. PubMed ID: 19394420
    [Abstract] [Full Text] [Related]

  • 20. Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the Rho family.
    Masamura K, Oida K, Kanehara H, Suzuki J, Horie S, Ishii H, Miyamori I.
    Arterioscler Thromb Vasc Biol; 2003 Mar 01; 23(3):512-7. PubMed ID: 12615662
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.